ATP6J/ATP6V1G1 Antibody

    应用:
  • WB
功能和特点
  • 宿主种属: 兔(Rabbit)
  • 种属反应性: 人(Human), 大鼠(Rat), 小鼠(Mouse)
  • 亚型: Rabbit IgG
  • 偶联: Unconjugated
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab090147-10μl
10μl 期货 Stock Image
Ab090147-50μl
50μL 现货 Stock Image
Ab090147-100μl
100μL 现货 Stock Image
Ab090147-1ml
1ml 期货 Stock Image

基本信息

产品名称 ATP6J/ATP6V1G1 Antibody
别名 兔多克隆抗体to ATP6J/ATP6V1G1 | ATP6J/ATP6V1G1 抗体
英文别名 ATP 6G antibody | ATP 6J antibody | ATP6G antibody | ATP6G1 antibody | ATP6GL antibody | Atp6v1g1 antibody | ATPase H+ transporting lysosomal (vacuolar proton pump) member J antibody | ATPase H+ transporting lysosomal 13kD V1 subunit G isoform 1antibody |
规格或纯度 ExactAb™, Validated, Carrier Free, 0.5 mg/mL
宿主种属 兔(Rabbit)
特异性 ATP6V1G1
种属反应性 人(Human),大鼠(Rat),小鼠(Mouse)
免疫原 A KLH conjugated synthetic peptide from the C-terminal region of human ATP6V1G1 (AA 90-118).
阳性对照 WB: MCF7, SK-N-SH, HeLa and C6 cell lysates.
偶联 Unconjugated

产品属性

克隆类型 多克隆抗体
Format Whole IgG
亚型 Rabbit IgG
SDS-PAGE 150 kDa
纯化方法 Protein A purified + Peptide affinity purified
物理外观 Liquid
储存缓冲液 10mM PBS, 0.09% Sodium azide, pH 7.4
防腐剂 0.09% Sodium azide
浓度 0.5 mg/mL
储存温度 -20°C储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 4°C 短期储存(1-2 周)。-20°C下长期保存(24个月)。收货后建议分装。避免冷冻/解冻循环。
分子类型 抗体

图片

ATP6J/ATP6V1G1 Antibody (Ab090147) - Western Blot
All lanes: ATP6J/ATP6V1G1 Antibody (Ab090147) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution

Predicted band size: 14 kDa
Observed band size: 16 kDa
Exposure time: 13.4 s

关联靶点(人)

ATP6V1G1 Tbio V型质子ATP酶亚基G1(V-type proton ATPase subunit G 1) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

安全和危险性(GHS)

质量标准

应用

应用名称 稀释比例
WB

1/1000

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到2个结果

批号(Lot Number) 证书类型 日期 货号
ZJ23F1202041 分析证书 23-12-14 Ab090147
ZJ23F1202042 分析证书 23-12-14 Ab090147

参考文献

1. Qin A, Cheng TS, Pavlos NJ, Lin Z, Dai KR, Zheng MH.  (2012)  V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption..  Int J Biochem Cell Biol,  44  (9): (1422-35).  [PMID:22652318]
2. David, P P, Nguyen, H H, Barbier, A A and Baron, R R..  (1996)  The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase..  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,  [PMID:8889850]
3. Mao, M M and 16 more authors..  (1998)  Identification of genes expressed in human CD34(+) hematopoietic stem/progenitor cells by expressed sequence tags and efficient full-length cDNA cloning..  Proceedings of the National Academy of Sciences of the United States of America,  (7): [PMID:9653160]
4. Smith, Annabel N AN, Borthwick, Katherine J KJ and Karet, Fiona E FE..  (2002)  Molecular cloning and characterization of novel tissue-specific isoforms of the human vacuolar H(+)-ATPase C, G and d subunits, and their evaluation in autosomal recessive distal renal tubular acidosis..  Gene,  (4): [PMID:12384298]
5. Humphray, S J SJ and 147 more authors..  (2004)  DNA sequence and analysis of human chromosome 9..  Nature,  (27): [PMID:15164053]
6. Miles, Anna L AL, Burr, Stephen P SP, Grice, Guinevere L GL and Nathan, James A JA..  (2017)  The vacuolar-ATPase complex and assembly factors, TMEM199 and CCDC115, control HIF1α prolyl hydroxylation by regulating cellular iron levels..  eLife,  (15): [PMID:28296633]
7. Duan, Xiaohong; Yang, Shaoqing; Zhang, Lei and Yang, Tielin..  (2018)  V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis..  Theranostics,  [PMID:30555553]
8. Thomas R Burkard,Melanie Planyavsky,Ines Kaupe,Florian P Breitwieser,Tilmann Bürckstümmer,Keiryn L Bennett,Giulio Superti-Furga,Jacques Colinge.  (2011-01-29)  Initial characterization of the human central proteome..  BMC systems biology,  (17-17).  [PMID:21269460]

溶液计算器